about
Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile.Design and immunological evaluation of anti-CD205-tailored PLGA-based nanoparticulate cancer vaccine.Targeted Therapeutic Nanoparticles: An Immense Promise to Fight against Cancer.Advances in the treatment of relapsing-remitting multiple sclerosis: the role of pegylated interferon β-1a.Potentiating Antigen Specific Immune Response by Targeted Delivery of the PLGA-Based Model Cancer Vaccine
P50
description
researcher ORCID ID = 0000-0002-9997-7756
@en
wetenschapper
@nl
name
Azita Haddadi
@ast
Azita Haddadi
@en
Azita Haddadi
@es
Azita Haddadi
@nl
type
label
Azita Haddadi
@ast
Azita Haddadi
@en
Azita Haddadi
@es
Azita Haddadi
@nl
prefLabel
Azita Haddadi
@ast
Azita Haddadi
@en
Azita Haddadi
@es
Azita Haddadi
@nl
P31
P496
0000-0002-9997-7756